Advertisement

Pharmacy World & Science

, 31:648 | Cite as

Care of the stroke patient—communication between the community pharmacist and prescribers in the Republic of Ireland

  • Tamasine GrimesEmail author
  • Catherine Duggan
  • Paul Gallagher
  • Judith Strawbridge
Research Article

Abstract

Objective This study sought to examine the perceptions that community pharmacists have of communication with prescribers in both primary and secondary care in Ireland, with respect to care of stroke patients. Setting Community pharmacies across Ireland, stratified into the four representative administrative regions. Method Survey using a structured postal questionnaire. Main outcome measure Perceptions of communication with prescribers based in primary and secondary care; pharmacy and pharmacy premises demographics. Results A response rate of 52% (n = 314) was achieved. Community pharmacists’ perceptions of information provision from secondary care were low, the majority (83%) never received any information from the hospital, although they would welcome it. Communication with hospital based prescribers was considered by most (93%) to be poor. The majority (greater than 75%) of respondents expressed a desire for greater information provision concerning a stroke patient’s medication and diagnostic information. Pharmacists’ perceptions of interaction with general practitioners were generally regarded as good (63%) although information provision in both directions between pharmacist and general practitioner could be improved. Conclusion The findings of this study indicated that community pharmacists perceive that there is room for improvement in the communication between themselves and prescribers in the primary and secondary care settings, concerning the care of the stroke patient. This highlights the need for the development of formal communication channels between community pharmacists and other members of the healthcare team involved in the care of the stroke patient. However, the challenges of communicating patient information across healthcare sectors are recognized.

Keywords

Cerebrovascular accident Communication Community pharmacy Ireland Medication reconciliation Medication safety Stroke 

Notes

Acknowledgments

We acknowledge the input of Coman Hennelly, Fionnuala Coleman, Kathleen Morgan and Lorna Conlan in administering the questionnaires and inputting data; the support of Prof. Hannah McGee, Dr Anne Hickey and Dr Frances Horgan for their comments and review through out the entire project. We also acknowledge the support of Dr James Barlow in reviewing drafts of the manuscript.

Funding

None declared.

Conflict of interests statement

None declared.

References

  1. 1.
    Mackay J, Mensah GA. The atlas of heart disease and stroke. Geneva: World Health Organization; 2004.Google Scholar
  2. 2.
    Horgan F, Hickey A, McGee H, O’Neill D. Irish National Audit of Stroke Care. Dublin: Irish Heart Foundation; 2008. http://www.irishheart.ie/iopen24/pub/strokereports/stroke_report.pdf.
  3. 3.
    Council on Stroke of the Irish Heart Foundation. Towards excellence in stroke care in Ireland. Dublin: Irish Heart Foundation; 2000.Google Scholar
  4. 4.
    Health Services Executive. National shared services primary care reimbursement services. Statistical analysis of claims and payments. Dublin. 2007. http://www.hse.ie/eng/PCRS/PCRS_Publications/2007_Report.pdf).
  5. 5.
    Lyons R, Rudd AG. Health policy and outcomes 2006. Stroke. 2007;38(2):229–31. doi: 10.1161/01.STR.0000254943.29376.e8.CrossRefPubMedGoogle Scholar
  6. 6.
    Struijs JN, van Genugten MLL, Evers SMAA, Ament AJH, Baan CA, van den Bos GAM. Future costs of stroke in the Netherlands: the impact of stroke services. Int J Technol Assess Health Care. 2006;22(4):518–24. doi: 10.1017/S0266462306051464.CrossRefPubMedGoogle Scholar
  7. 7.
    Cook RI, Render M, Woods DD. Gaps in the continuity of care and progress on patient safety. BMJ. 2000;18;320(7237):791–4.Google Scholar
  8. 8.
    Duggan C, Feldman R, Hough J, Bates I. Reducing adverse prescribing discrepancies following hospital discharge. Int J Pharm Pract. 1998;6:77–82.Google Scholar
  9. 9.
    Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. Adverse drug events occurring following hospital discharge. J Gen Intern Med. 2005;20(4):317–23. doi: 10.1111/j.1525-1497.2005.30390.x.CrossRefPubMedGoogle Scholar
  10. 10.
    Hammerlein A, Griese N, Schulz M. Survey of drug-related problems identified by community pharmacies. Ann Pharmacother. 2007;41(11):1825–32. doi: 10.1345/aph.1K207.CrossRefPubMedGoogle Scholar
  11. 11.
    Minister for Health and Children. Regulation of retail pharmacy businesses regulations, Statutory Instrument (S. I). no. 488 of 2008. ISBN 978-1-4064-4366-0. http://www.attorneygeneral.ie/esi/2008/B26511.pdf).
  12. 12.
    Royal College of Physicians. National sentinel stroke audit phase I (organisational audit) 2006 phase II (clinical audit) 2006. London; 2007.Google Scholar
  13. 13.
    Smith F. Health services research methods in pharmacy: survey research. Part 1. Design, samples and response. Int J Pharm Pract. 1997;5:152–66.Google Scholar
  14. 14.
    Crawford VLS, Dinsmore JG, Stout RW, Donnellan C, O’Neill D, McGee H. Stroke presentation and hospital management. Comparison of neighbouring healthcare systems with differing health policies. Stroke. 2009;40 (published online before print 16 Apr 2009). doi:  10.1161/STROKEAHA.108.545376.
  15. 15.
    Howard R, Avery AJ, Bissell P. Causes of preventable drug-related hospital admissions: a qualitative study. Qual Saf Health Care. 2008;17(2):109–16. doi: 10.1136/qshc.2007.022681.CrossRefPubMedGoogle Scholar
  16. 16.
    Grimes T. The quality of medication information imparted at acute hospital discharge. Crossing the quality chasm from hospital to home. Medication Safety Seminar, 2007; Dublin. Clinical Indemnity Scheme, 2007.Google Scholar
  17. 17.
    Grimes T, Delaney T, Kelly JG, Graham IM. Medicines management immediately post hospital discharge. Implications for communication and safety. Ir Pharm J. 2008;86(2):8–14.Google Scholar
  18. 18.
    Barry PJ, Gallagher P, Ryan C, O’Mahony D. START (screening tool to alert doctors to the right treatment)–an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing. 2007;36(6):632–8. doi: 10.1093/ageing/afm118.CrossRefPubMedGoogle Scholar
  19. 19.
    Clifford S, Barber N, Elliott R, Hartley E, Horne R. Patient-centred advice is effective in improving adherence to medicines. Pharm World Sci. 2006;28(3):165–70. doi: 10.1007/s11096-006-9026-6.CrossRefPubMedGoogle Scholar
  20. 20.
    Health Services Executive. Code of practice for integrated discharge planning, Dublin. 2008. http://www.hse.ie/eng/Publications/Hospitals/Code_of_practice_for_integrated_discharge_planning.pdf).
  21. 21.
    Madden D. Building a culture of patient safety. Report of the commission on patient safety and quality assurance. Dublin: Department of Health and Children; 2008. ISBN 978-1-4064-2183-5.Google Scholar
  22. 22.
    Bolas H, Brookes K, Scott M, McElnay J. Evaluation of a hospital-based community liaison pharmacy service in northern Ireland. Pharm World Sci. 2004;26(2):114–20. doi: 10.1023/B:PHAR.0000018601.11248.89.CrossRefPubMedGoogle Scholar
  23. 23.
    Vuong T, Marriott JL, Kong DC, Siderov J. Implementation of a community liaison pharmacy service: a randomised controlled trial. Int J Pharm Pract. 2008;16(3):127–35. doi: 10.1211/ijpp.16.3.0002.CrossRefGoogle Scholar
  24. 24.
    Martin B, Yip B, Hearty M, Marletta S, Hill R. Outcome, functional recovery and unmet needs following acute stroke. Experience of patient follow-up at 6 to 9 months in a newly established stroke service. Scott Med J. 2002;6:136–7.Google Scholar
  25. 25.
    Britten N, Stevenson FA, Barry CA, Barber N, Bradley CP. Misunderstandings in prescribing decisions in general practice: qualitative study. BMJ. 2000;320(7233):484–8. doi: 10.1136/bmj.320.7233.484. (see comment).CrossRefPubMedGoogle Scholar
  26. 26.
    Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract. 2003;53(493):600–6.PubMedGoogle Scholar
  27. 27.
    Cross M. Will connecting for health deliver its promises? BMJ. 2006;332(7541):599–601. doi: 10.1136/bmj.332.7541.599.CrossRefPubMedGoogle Scholar
  28. 28.
    Cross M. Computer says yes—and no. BMJ. 2007;334(7608):1350–1. doi: 10.1136/bmj.39259.445035.34.CrossRefPubMedGoogle Scholar
  29. 29.
    Cross M. Problems with computerising patients’ records are “as serious as ever”, say MPs. BMJ. 2009;338:b337. doi: 10.1136/bmj.b337.CrossRefGoogle Scholar
  30. 30.
    Department of Health and Children. Primary care—a new direction. Dublin: Government Publishing Office; 2001. ISBN 0-7557-1179-3. http://www.dohc.ie/publications/primary_care_a_new_direction.html).
  31. 31.
    Barber N. What constitutes good prescribing? BMJ. 1995;310(6984):923–5.PubMedGoogle Scholar
  32. 32.
    Government HM. Pharmacy in England. Building on strength—delivering the future. Norwich: Crown copyright; 2008.Google Scholar
  33. 33.
    Maddux MS, Dong BJ, Miller WA, Nelson KM, Raebel MA, Raehl CL, et al. A vision of pharmacy’s future roles, responsibilities, and manpower needs in the United States. Pharmacotherapy. 2000;20(8 I):991–1020.Google Scholar
  34. 34.
    Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and general practitioners in the United Kingdom. Soc Sci Med. 2001;53(7):943–55. doi: 10.1016/S0277-9536(00)00393-2.CrossRefPubMedGoogle Scholar
  35. 35.
    Zillich AJ, McDonough RP, Carter BL, Doucette WR. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother. 2004;38(5):764–70. doi: 10.1345/aph.1D419.CrossRefPubMedGoogle Scholar
  36. 36.
    Zillich AJ, Milchak JL, Carter BL, Doucette WR. Utility of a questionnaire to measure physician-pharmacist collaborative relationships. J Am Pharm Assoc JAPhA. 2006;46(4):453–8. doi: 10.1331/154434506778073592.CrossRefGoogle Scholar
  37. 37.
    Bowling A. Mode of questionnaire administration can have serious effects on data quality. J Public Health. 2005;27(3):281–91. doi: 10.1093/pubmed/fdi031.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Tamasine Grimes
    • 1
    Email author
  • Catherine Duggan
    • 2
    • 3
  • Paul Gallagher
    • 4
  • Judith Strawbridge
    • 4
  1. 1.Adelaide and Meath Hospital, incorporating the National Children’s HospitalDublin 24Ireland
  2. 2.Clinical Pharmacy—Development and Evaluation for East and South East England Specialist ServicesNHSLondonUK
  3. 3.The School of PharmacyLondonUK
  4. 4.School of PharmacyRoyal College of Surgeons in IrelandDublin 2Ireland

Personalised recommendations